Evome Medical Technologies Inc.
LNDZF
$0.0041
-$0.0027-39.71%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -137.82% | -100.95% | -158.61% | -213.61% | 129.66% |
| Total Depreciation and Amortization | -154.61% | -30.63% | 11.10% | 49.78% | 105.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.34% | 1,088.42% | 39.43% | 169.68% | -141.91% |
| Change in Net Operating Assets | 379.24% | 29.76% | 409.25% | 228.43% | 68.28% |
| Cash from Operations | 1,759.57% | 379.46% | 25.46% | -27.44% | 96.81% |
| Capital Expenditure | 76.83% | 100.00% | 58.64% | 104.13% | 28.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.83% | 100.00% | 58.64% | 101.52% | 97.92% |
| Total Debt Issued | 232.38% | -43.76% | -- | 17.79% | -151.17% |
| Total Debt Repaid | -431.55% | -512.42% | 32.56% | 82.79% | 193.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8,416.33% | -1,014.67% | -109.93% | 72.43% | -99.18% |
| Foreign Exchange rate Adjustments | 242.13% | -16.45% | 103.89% | 413.87% | -386.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.58% | 135.95% | -138.95% | 97.66% | 93.51% |
